MedPharma is a pharmaceutical company based in the United Kingdom that provides medication and healthcare products.

MedPharma

The Robert Wood Johnson Foundation is a philanthropic organization dedicated to improving health and healthcare in the United States. It focuses on addressing social determinants of health, health equity, and access to quality healthcare.

Robert Wood Johnson

Robert Wood Johnson Foundation

bit.bio specializes in synthetic biology for human health, providing a platform for deterministic cell programming and manufacturing human cell types at scale with precision and consistency.

bit.bio

Abbott develops and delivers health care technologies and products. The company focuses on various sectors of health care, including diagnostics and nutrition. Self-described as a provider of life-changing solutions.

Abbott

MedPharma UK is a pharmaceutical company providing medical and healthcare products in the United Kingdom

MedPharma UK

MedPharm | 14,474 followers on LinkedIn. Breaking through boundaries | Getting a promising new topical or transepithelial product from lab to patient is challenging. Making it all the way through the development pipeline will be time-consuming, risky, and unpredictable. That’s why it makes sense to think ahead and partner with the experts who can give pharma companies like yours more opportunities for success, every step of the way.

Board Member. Former CEO. Investor.

Amit Patel

CEO & President, MedPharm Consulting, Inc, Philanthropist and Life Sciences and Devices Quality and Regulatory Consulting

Gary Gilliam

Chief Scientific Officer at MedPharm Ltd

Jon Lenn

Chief Financial Officer at MedPharm

Peter Geiger

MedPharm

BIO Europe Fall starts next week! It's not too late to reach out through our website or in the event platform to schedule a time to meet with @Kasia Niemiec and @Charles Evans during the event. https://hubs.la/Q02VhDbJ0 https://hubs.la/Q02VhD600

We are thrilled to add Vincent Avery, MBA to our team--welcome to MedPharm!

Next month, MedPharmer @Kasia Niemiec will be in Stockholm, Sweden for BIO Europe Fall. Send her a message in the event platform to schedule a time to catch up, and comment below if we'll see you there! https://hubs.la/Q02PwMDK0

MedPharm's Kasia Niemiec , Charles Evans , and Stephanie Proesel, MBA are ready to do business at CPhI Milan. They are looking forward to meeting with current and prospective clients to discuss how MedPharm can help drive their topical, transdermal, and transepithelial drug products forward.

Happening this week!! CPHI Milan is in full swing and we are so excited to see everyone. If you haven't already, be sure to stop by Booth 7B99 to meet our team, or send us a message in the event platform to schedule a meeting: https://hubs.la/Q02RcGPN0 Informa #CPHIMilan #CPHI35Years

The countdown to CPHI Milan continues! In less than TWO WEEKS MedPharm BD Manager, Kasia Niemiec , will attend the show along with Charles Evans , our SVP of Pharmaceutical Development and other MedPharm team members. Reach out to us in the platform or through our website to schedule a meeting during the event. And be sure to stop by Booth 7B99 to say hi to the team during the show! https://hubs.la/Q02Pw3fJ0 Informa #CPHIMilan #CPHI35Years

Happening this week! Stop by table #62 at Contract Pharma Contracting & Outsourcing Conference to catch up with the MedPharm team. Comment below if we'll see you there. ⬇️⬇️

MedPharm's Senior BD Director, Tim Miley , will be in New Brunswick, NJ on September 26th for the Contract Pharma Contracting & Outsourcing Conference! Stop by MedPharm's table #62 during the show, or schedule a meeting with Tim through our website: https://hubs.la/Q02Pv_J00

Only 34 days until CPHI Milan 2024! Our BD Manager Kasia Niemiec and other members of the MedPharm team will be in attendance. Stop by our booth 7B99, or reach out through our website to schedule a meeting with the team: https://lnkd.in/dB2CPJ-Y Informa #CPHI #CPHIMilan #CPHI35Years #AtTheHeartOfPharma

#ICYMI ... We recently announced that MedPharm and Tergus have joined forces to establish the best-in-class end-to-end CDMO specializing in topical and transepithelial drug products. Read the full announcement or reach to us today for more information: https://lnkd.in/ee-AK72G

Metric
Company Name	MedPharma	Robert Wood Johnson Foundation	bit.bio	Abbott
Symbol
MSH ID	UK:MEDPHARMA	ORG:RWJF	BIO:BIT	COM:ABBOTT
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Healthcare and Philanthropy	Biotechnology	Medical Devices and Diagnostics
Country	GB		GB	US
Stage	Venture Round
Employee Count		501		10.00K
Website	medpharma.uk	rwjf.org	bit.bio	abbott.com
LinkedIn	medpharm
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.50K	73.98K	873.36K
Web Traffic Growth	-0.24	-0.26	-0.14
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MEDP

UK:MEDPHARMA

MedPharma UK

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue